WAM
BLUE

Wolverine Asset Management’s bluebird bio BLUE Stock Holding History

Wolverine Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed -$4K – 2174
2021
Q1 		$4K Sell
13
-260
-95% -$128K ﹤0.01% 1934
2020
Q4 		$153K Buy
273
+189
+225% +$120K ﹤0.01% 1133
2020
Q3 		$58K Sell
84
-1
-1% -$780 ﹤0.01% 1232
2020
Q2 		$67K Buy
+85
New +$64.1K ﹤0.01% 1174
2020
Q1 		– Sell
-7
Closed -$7K – 1451
2019
Q4 		$7K Hold
7
– – ﹤0.01% 1292
2019
Q3 		$8K Hold
7
– – ﹤0.01% 1316
2019
Q2 		$11K Hold
7
– – ﹤0.01% 1307
2019
Q1 		$13K Buy
+7
New +$12.3K ﹤0.01% 1262

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Wolverine Asset Management's BLUE Position: Q2 2021 in Review

Wolverine Asset Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 13 shares — an estimated $4K sold.

Wolverine Asset Management first reported a position in BLUE in Q1 2019 and held it in 8 quarters. The position peaked at $153K in Q4 2020. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Wolverine Asset Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 13 bluebird bio shares in Q2 2021, an estimated $4K.
  • Wolverine Asset Management first reported a position in bluebird bio in Q1 2019 and held it in 8 quarters.
  • Wolverine Asset Management's bluebird bio position peaked at $153K in Q4 2020.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.